Following firstpennypicks.com 100% uncompensated alerts
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NHPI DD report
Our new profile Neuro-Hitech, Inc. (OTCPink: NHPI)
Published February 12, 2013 | Edit
NHPI just uploaded 18 filings on January 29th, 2013. This caught our attention and eventually lead to the due diligence report you see below. Could this be a casualty of the 2008 economy looking to re-list on the Nasdaq Exchange?
Sometimes we catch a security to profile as it’s coming back to life, these can sometimes be giants in the making for those that get in early and this one is already starting to heat up so we wanted to get it out ASAP to our members since WE ARE FIRST penny picks and everyone wants to be like us. On a more serious note, the last quarter’s accounts receivable as you can see below is just shy of the current market cap, can you say whaaa? Undervalued is an understatement if we can eventually substantiate these numbers with some audited financials, that could be exactly where this one is heading.
NHPI Security Details
Share Structure
Market Value1 $785,223 a/o Feb 08, 2013
Shares Outstanding 31,408,909 a/o Dec 31, 2012
Float Not Available (we are assuming since these are the same numbers from the 2009 audited report that 31,408,909 is the current public float as well)
Authorized Shares 49,999,900 a/o Jan 21, 2013
Par Value 0.001
Shareholders
Shareholders of Record 123 a/o Apr 29, 2008
Security Notes
Note = deleted from NASDAQ on 04/02/08
Website: http://www.mcramerican.com/
From the last 10-Q filed period ending March 31st, 2009
1] Nature of Operations
Neuro-Hitech, Inc. (Otcpink: NHPI) is a specialty pharmaceutical company focused on developing, marketing and distributing branded and generic pharmaceutical products primarily in the cough and cold markets. The Company sells its products domestically through U.S. based distributors.
On June 6, 2008, the Company acquired the capital stock of MCR American Pharmaceuticals, Inc., a Florida corporation (“MCR”) and AMBI Pharmaceuticals, Inc., a Florida corporation (“AMBI”) pursuant to an Amended and Restated Stock Purchase Agreement (the “Purchase Agreement”), by and among the Company, GKI Acquisition Corporation, the Company’s wholly-owned subsidiary (“GKI”), and David Ambrose (“Seller”), the sole stockholder of MCR and AMBI.
Prior to June 6, 2008, the Company had been focused primarily on technologies that address investigational compounds that have the potential to show clinical improvements versus current treatments for Alzheimer’s disease, Epilepsy and other central nervous system applications. The Company’s most advanced product candidate targeting these needs is Huperzine A which completed a Phase II clinical trial in the U.S. in 2008 for efficacy and safety in the treatment of mild to moderate Alzheimer’s disease. In addition to Huperzine A, the Company has worked on two pre-clinical development programs: one for second generation anti-amyloid compounds or disease modifying drugs for Alzheimer’s disease and, secondly, development of a series of compounds targeted to treat and prevent epilepsy.
In view of the results of the Phase II clinical trial, the cost associated with additional trials, and the acquisition of MCR and AMBI, the Company is principally focusing on the development, marketing and distribution of branded and generic pharmaceutical products targeted to the cough and cold markets. The Company continues to explore the potential development of collaborative, joint and strategic alliances and licensing arrangements with one or more pharmaceutical companies for the further development of Huperzine A and its pipeline of other compounds.
NOTE* During the above period the company had gross profits for the three months ending March 31st, 2009 of $304,558.00
Unaudited quarterly reports filed January 29th, 2013
For the three months ending December 31st, 2012 (unaudited quarterly report-otcmarkets.com) AMBI Pharmaceuticals is showing accounts receivable in the amount of $256,067.05 and MCR American Pharmaceuticals accounts receivable during the same period of $350,270.12 for a total last quarterly reported accounts receivable of $606,337.17
This could be an all-star in the making. Please be patient we have not forgot about our stocks in play and we will be back with updates soon.
(We have NOT been compensated for the profile of NHPI)
New* Receive our mobile alerts by texting “FPPalerts” to 25827
other than the 100k at .0399 the level two has cleared and lined up for a move.
Your exactly right street, this is just starting
NHPI just heating up 30M float massive rev's coming alive
PERT is positioned for major growth!
Hey Ageless check this out it should help with your timing
http://www.marketwire.com/press-release/elite-traders-group-announces-179-vip-member-slots-remain-open-until-its-300-member-1747779.htm
Will do and thank you
I own Elite Traders Group and First penny picks and I would like to clarify for everyone here that RTGV has not compensated us or anyone as far as I can see for awareness or promotional activity. We like RTGV and we sometimes are not compensated nor do we necessarily communicate with the companies we profile.
Sorry for the confusion , future PR's will disclose the non-compensation if it applies.
Should anyone want to verify who we are email us at info @ first penny picks .com
Yeah we are working on that
Let me clarify again we did not promote nor do we plan to promote MMRF that PR is designed to build awareness about us and mention a few promising companies. We are not going to profile MMRF to our subscribers!
no problem anytime, we take pride in the fact that we are readily accessible by the investment community and public companies.
I own Elite Traders Group and First penny picks and I would like to clarify for everyone here that MMRF has not compensated us or anyone as far as I can see for awareness or promotional activity. We like MMRF and we sometimes are not compensated nor do we necessarily communicate with the companies we profile.
Sorry for the confusion , future PR's will disclose the non-compensation if it applies.
Should anyone want to verify who we are email us at info @ first penny picks .com
nice find, not sure if it will benefit MWIP though
No doubt money runners had little to no effect since they started in December. It's obvious FPP has done their job since October!
WTII getting some attention low float and 52 week high of 5x current pps
WTII is thin and seeing a lil action today
We dont understand what you mean about us abusing ignorance of penny traders please elaborate? The section you quoted above that comment was disseminated to our group yesterday.
MWip is definitely not a pump, to insinuate that is just ridiculous
We alerted it on Oct.12th at .0027 Firstpennypicks
Wow,MWIP is offering up oppurtunity now. It looks like shorts/bashers are showing up here and being successful. It's up to longs too ride it out or buy into the BS, Ive seen it a thousand times and I know you guys have too. Let it consolidate to move up. Raff and the company are not selling they are buying, this is the opp. of a lifetime for a penny trader its still up 1000% from our initial coverage 3 months ago. What does that tell ya.
MWIP is still a major part of the overall picture without 800 commerce and should have increasing revenues regardless. as far as the spinoff who doesnt want IPO shares of a company with massive revenues?
No doubt about it!
NEW ARTICLE MWIP http://mmjbusinessdaily.com/2013/01/09/unconventional-wisdom-mmj-firm-bypasses-hotspots-out-west-to-focus-on-michigan-east-coast/
and ye evryone buying prior to the record date qualifies for divy!
It's possible J/V, Merger, who knows
Very rarely, This is the kind of liquidity event you want to ride for the long haul. But what do i know only been trading micro-caps for 15 years.
No doubt about it!
easily .05-.10 in the next two weeks ! mark this post
MWIP now up 1000% from our Oct. Alert at .0025/share, however we feel the best is yet to come!!!!!!!!!!!!!!Your guys at FPP
No doubt this should be .25-.50 by mid end Jan. IMO
EPOR news out 1.06/share valuation and 7M float current .07
EPOR news out 1.06/share valuation and 7M float current .07
Remember First Penny Picks brought you the spin-off report Oct. 12th at .0027/share !
Congrats
Excellent news, I know! This one's a no brainer.
EPOR has pulled back under .09 low float very this to .15
current .05 was .55/share earlier this year. Hearing promo coming